NCT04003636 2026-03-24KEYNOTE-966Merck Sharp & Dohme LLCPhase 3 Completed1,069 enrolled 19 charts 2 FDA
NCT03675737 2026-02-27KEYNOTE-859Merck Sharp & Dohme LLCPhase 3 Completed1,579 enrolled 31 charts 2 FDA
NCT03615326 2025-12-11MK-3475-811Merck Sharp & Dohme LLCPhase 3 Completed738 enrolled 22 charts 7 FDA
NCT03189719 2024-10-15KEYNOTE-590Merck Sharp & Dohme LLCPhase 3 Completed749 enrolled 40 charts 2 FDA
NCT02335411 2022-08-08KEYNOTE-059Merck Sharp & Dohme LLCPhase 2 Completed318 enrolled 24 charts 2 FDA